ITIH5 and breast carcinoma: To give insight into ITIH5 biology going beyond the assumed role as a prognostic biomarker in breast carcinomas, we established two different stable gain-of-function models, i.e. weak-aggressive T47D and metastatic MDA-MB-231 single-cell clones overexpressing full-length ITIH5.